These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24262639)

  • 1. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen H; Isometsä E
    J Affect Disord; 2014 Feb; 155():110-7. PubMed ID: 24262639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of long-term work disability among patients with type I and II bipolar disorder: a prospective 18-month follow-up study.
    Arvilommi P; Suominen K; Mantere O; Valtonen H; Leppämäki S; Isometsä E
    Bipolar Disord; 2015 Dec; 17(8):821-35. PubMed ID: 26621076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen HM; Isometsä E
    J Affect Disord; 2010 Feb; 121(1-2):116-26. PubMed ID: 19497622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder.
    Sajatovic M; Micula-Gondek W; Tatsuoka C; Bialko C
    Gend Med; 2011 Aug; 8(4):261-8. PubMed ID: 21763217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment adherence with antipsychotic medications in bipolar disorder.
    Sajatovic M; Valenstein M; Blow FC; Ganoczy D; Ignacio RV
    Bipolar Disord; 2006 Jun; 8(3):232-41. PubMed ID: 16696824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and psychosocial treatment of depression in primary care: Low intensity and poor adherence and continuity.
    Vuorilehto MS; Melartin TK; Riihimäki K; Isometsä ET
    J Affect Disord; 2016 Sep; 202():145-52. PubMed ID: 27262636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.
    Levin JB; Tatsuoka C; Cassidy KA; Aebi ME; Sajatovic M
    Compr Psychiatry; 2015 Apr; 58():29-36. PubMed ID: 25617964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence and the use of long-acting antipsychotics in bipolar disorder.
    El-Mallakh RS
    J Psychiatr Pract; 2007 Mar; 13(2):79-85. PubMed ID: 17414683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study.
    Pallaskorpi S; Suominen K; Ketokivi M; Mantere O; Arvilommi P; Valtonen H; Leppämäki S; Isometsä E
    Bipolar Disord; 2015 Jun; 17(4):363-74. PubMed ID: 25726951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing medication adherence in patients with bipolar disorder.
    Berk L; Hallam KT; Colom F; Vieta E; Hasty M; Macneil C; Berk M
    Hum Psychopharmacol; 2010 Jan; 25(1):1-16. PubMed ID: 20041478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
    Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
    Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders.
    Manwani SG; Szilagyi KA; Zablotsky B; Hennen J; Griffin ML; Weiss RD
    J Clin Psychiatry; 2007 Aug; 68(8):1172-6. PubMed ID: 17854240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.
    Sajatovic M; Ignacio RV; West JA; Cassidy KA; Safavi R; Kilbourne AM; Blow FC
    Compr Psychiatry; 2009; 50(2):100-7. PubMed ID: 19216885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder.
    Sajatovic M; Biswas K; Kilbourne AK; Fenn H; Williford W; Bauer MS
    Psychiatr Serv; 2008 Jul; 59(7):753-9. PubMed ID: 18586992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
    Miklowitz DJ; Otto MW; Frank E; Reilly-Harrington NA; Kogan JN; Sachs GS; Thase ME; Calabrese JR; Marangell LB; Ostacher MJ; Patel J; Thomas MR; Araga M; Gonzalez JM; Wisniewski SR
    Am J Psychiatry; 2007 Sep; 164(9):1340-7. PubMed ID: 17728418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor Adherence to Oral Psychiatric Medication in Adults with Bipolar Disorder: The Psychiatrist May have More Influence than in Other Severe Mental Illnesses.
    De Las Cuevas C; Villasante-Tezanos GA; Motuca M; Baptista T; Lazary J; Pogany L; De Leon J
    Neuropsychopharmacol Hung; 2021 Dec; 23(4):347-362. PubMed ID: 34971399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.